Last edition
News about "novel oncology supportive care injectable in US"
Zydus Inks Exclusive Deal with RK Pharma for Novel Oncology Supportive Care Injectable in US
Zydus Lifesciences Ltd., along with its subsidiaries and affiliates, has entered into an exclusive licensing and commercialization agreement with US-based RK Pharma Inc for a novel sterile injectable developed under the 505(b)(2) pathway for oncology supportive care in the United States.
Novel Oncology Supportive Care Injectable In US | 26/11/2025 | By Darshana
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members